Physician profile
Aisha Rahman
NPI 1912196114
$3,578.93
in general payments reported to CMS, 2019-2025
16 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $658 · 2020: $282 · 2021: $347 · 2022: $577 · 2023: $816 · 2024: $517 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,709 · Travel and Lodging: $5.81.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,709.37 |
| Travel and Lodging | $5.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $989.80 | 2019-2024 | Senza |
| Boston Scientific Corporation | $942.31 | 2019-2024 | |
| Medtronic, INC. | $661.56 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Globus Medical, INC. | $198.37 | 2025 | Senza |
| Spr Therapeutics, INC | $186.29 | 2019-2023 | Sprint Pns System |
| Abbott Laboratories | $121.56 | 2022-2025 | Eterna, Proclaim |
| Flowonix Medical Incorporated | $118.90 | 2019-2020 | |
| Medtronic USA, INC. | $112.98 | 2019 | |
| Collegium Pharmaceutical, INC. | $54.41 | 2022 | |
| Grt US Holding, INC. | $45.00 | 2022 | |
| Bioventus LLC | $42.03 | 2021-2023 | Stimrouter Implantable Kit |
| Pfizer INC. | $26.92 | 2019 | |
| Averitas Pharma INC. | $22.38 | 2025 | Qutenza |
| Depuy Synthes Sales INC. | $21.53 | 2024 | Orthovisc, Monovisc |
| Vertex Pharmaceuticals Incorporated | $19.14 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tersera Therapeutics LLC | $15.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aisha Rahman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.